对药物进口的关税正在抬高美国的药物价格,伤害了医疗保险的接受者和无保险者。 Tariffs on drug imports are raising U.S. drug prices, hurting Medicare recipients and the uninsured.

对药品进口的关税,特别是对活性成分的关税,正在提高美国药物价格,影响到药品的获取和可负担性。 Tariffs on pharmaceutical imports, especially active ingredients, are raising drug prices in the U.S., affecting access and affordability. 这通过提高保险费、增加费用导致不服药而没有保险,以及增加保险费和自付费用,对医疗保险受益人产生影响。 This impacts Medicare recipients through higher premiums, the uninsured via increased costs leading to medication nonadherence, and insured individuals through higher premiums and out-of-pocket expenses. 政策制定者们正在研究解决这些问题的战略。 Policymakers are looking at strategies to address these issues.